The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

LifePoint Health Inc

Nasdaq: LPNT
Last

(U.S.) $84.02

Today's change0.00 0.00%
Updated July 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

LifePoint Health Inc

Nasdaq: LPNT
Last

(U.S.) $84.02

Today's change0.00 0.00%
Updated July 28 4:00 PM EDT. Delayed by at least 15 minutes.

LifePoint Health Inc closed at (U.S.)$84.02.

Shares have lost 0.59% over the last five days, but sit 4.72% below their 52-week high. This security has outperformed the S&P 500 by 9.49% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $84.02
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change+16.84%
  • Volume0
  • Average volume (10-day)216,779
  • Average volume (1-month)323,651
  • Average volume (3-month)369,178
  • 52-week range(U.S.) $62.95 to (U.S.) $88.18
  • Beta0.88
  • Trailing P/E30.46×
  • P/E 1 year forward20.98×
  • Forward PEG2.02×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.76
Updated July 28 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+2.94%

Based on its net profit margin of 2.94%, LifePoint Health Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue1,2641,2631,1661,047
Total other revenue--------
Total revenue1,2641,2631,1661,047
Gross profit456452427396
Total cost of revenue808811739651
Total operating expense1,1981,2231,120981
Selling / general / administrative258258243222
Research & development--------
Depreciation / amortization68606961
Interest expense (income), net operating--------
Unusual expense (income)1246120
Other operating expenses, total24202815
Operating income66404667
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax66404667
Income after tax42272942
Income tax, total24131725
Net income39222839
Total adjustments to net income--------
Net income before extra. items39222839
Minority interest-3-4-1-3
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items39222839
Inc. avail. to common incl. extra. items39222839
Diluted net income39222839
Dilution adjustment----0--
Diluted weighted average shares46464747
Diluted EPS excluding extraordinary itemsvalue per share0.840.480.590.84
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share1.001.150.750.84